Lecture

IP Management at AC Immune

Description

This lecture covers the intellectual property (IP) management strategies at AC Immune, a biotech company pioneering new therapies for neurodegenerative diseases. It discusses the company's IP portfolio, including patents, trademarks, and trade secrets, as well as the challenges and considerations in patent filing strategies in the biotech industry. The presentation emphasizes the importance of IP in product development, partnering opportunities, and the integration of IP in the overall business strategy. It also addresses topics such as Freedom to Operate, Bolar Exemption, Research Exemption, and the impact of biosimilars on blockbuster drugs.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.